•  The biosecurity crisis needs to continue indefinitely because it's the primary justification behind The Great Reset

•  In the fall of 2022, mainstream media started warning of a potential "tripledemic," with COVID, seasonal influenza and respiratory syncytial virus (RSV) being in circulation at the same time. The sudden focus on RSV just so happened to coincide with announcements that RSV vaccines were being fast-tracked

•  The U.S. Food and Drug Administration approved the first-ever RSV vaccines in the summer of 2023 for seniors 60 years and older — one by Pfizer (Abrysvo) and one by GlaxoSmithKline (Arexvy). Both vaccines are recombinant subunit vaccines, and both manufacturers have reported Guillain-Barré syndrome as a side effect

•  As we're heading into the fall of 2023, the "tripledemic" of COVID, RSV and influenza is again making headlines. A Google search for the key words "triple pandemic 2023" garnered a staggering 41.1 million articles, and as we saw all through the COVID pandemic, news agencies are using he exact same headlines and talking points. This is unequivocal evidence that the tripledemic narrative is being coordinated by a central source

•  For this fall, U.S. health officials recommend a flu vaccine for everyone 6 months old and older, an updated mRNA COVID-19 booster targeting the Omicron XBB.1.5 strain (specifics on who should get the shot and when are still undetermined) and an RSV vaccine for seniors 60 years old and older

In the fall of 2022, mainstream media started warning of a potential "tripledemic," with COVID,1 seasonal influenza and respiratory syncytial virus (RSV)2 being in circulation at the same time. Fear sells, they say, and that's certainly the adage used by Big Pharma when it comes to vaccines.